ProUroCare Medical Inc.
PUMD · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -4,011.83% | -11,586.78% | -4,493.90% | -17,240.15% |
| EV / EBITDA | -7.24 | -4.50 | -2.48 | -1.11 |
| Quality | ||||
| ROIC | 0.00% | 18.70% | 8.89% | 0.00% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | – | 0.37 | 0.17 | 0.47 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 65.27% | -159.00% | 73.24% | 0.29% |
| Safety | ||||
| Net Debt / EBITDA | -7.23 | -4.50 | -2.47 | -1.11 |
| Interest Coverage | -2.29 | -4.41 | -3.53 | -4.25 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |